Skip to content

Impact of a Statewide Teleneonatology Acute Network in Bavaria (Tele-NNAD) on Patient- and System-Relevant Outcomes Compared with Standard Care: A Stepped-Wedge Cluster Trial Using a DOOR Endpoint and Win Ratio Analysis

Impact of a Statewide Teleneonatology Acute Network in Bavaria (Tele-NNAD) on Patient- and System-Relevant Outcomes Compared with Standard Care: A Stepped-Wedge Cluster Trial Using a DOOR Endpoint and Win Ratio Analysis - Tele-NNAD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00039793
Enrollment
500
Registered
2026-03-31
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute neonatal emergencies short before/after birth.

Interventions

Group 1: Arm 1 (Intervention): 24/7 acute teleneonatology support via a hub-and-spoke network (real-time video consultation with a perinatal center) in predefined neonatal emergencies (“trigger cases”

Sponsors

KinderUniKlinik Ostbayern (KUNO), Klinik St. Hedwig, Barmherzige Brüder Regensburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Days to No maximum

Inclusion criteria

Inclusion criteria: Newborns delivered in one of the participating maternity units during the study period. Presence of at least one predefined neonatal trigger criterion (acute clinical condition requiring neonatal decision support) immediately after birth. Occurrence of at least one of the predefined trigger criteria from one of the 6 trigger groups A-F: A: Perinatal risk: Emergency delivery, silent CTG, placental abruption, uncovered uterine rupture, suspected perinatal asphyxia B: Resuscitation/severe primary adaptation disorder: Ongoing resuscitation (> 1 cycle of chest compressions), limp infant (> 5 initial ventilations with no response from the infant), umbilical cord pH 5 minutes D: Other acute emergencies: Persistent cyanosis (> 5 minutes) of any cause Severe recurrent hypoglycemia (<30 mg/dL), Suspected seizures E: Severe malformations: MMC, abdominal wall defects, atresia, cleft lip and palate, and others F: Prematurity <37 weeks of gestation: Prematurity <37 weeks of gestation

Exclusion criteria

Exclusion criteria: Newborns without any predefined trigger criterion. Births outside the participating maternity units. Newborns with missing or incomplete data required for the primary endpoint.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is a hierarchical Desirability of Outcome Ranking (DOOR) endpoint, compared between intervention and control phases using a win ratio analysis. WHAT: Composite endpoint consisting of four hierarchically ranked dimensions: (1) death or severe early morbidity/escalation within 24 hours after birth, (2) early clinical stability at 10 minutes (Apgar score), (3) transfer/escalation of care (need for transfer and clinical status before transport measured by the TRIPS-II score [Transport Risk Index of Physiologic Stability]), (4) time to first involvement of a neonatal expert. WHEN: Dimension (1): within the first 24 hours of life Dimension (2): at 10 minutes (Apgar score) Dimension (3): during initial care until transfer decision / prior to transport Dimension (4): time interval from first clinical abnormality (trigger criterion) to first documented expert involvement HOW: Data are obtained from routine clinical care and medical records: Apgar score (standardized clinical scoring system), TRIPS-II score (Transport Risk Index of Physiologic Stability), documentation of escalation measures, interventions, and mortality, timestamps of clinical events and telemedical contacts. Evaluation follows a predefined hierarchical ranking of the DOOR components.

Secondary

MeasureTime frame
No secondary endpoints have been defined.

Countries

Germany

Contacts

Public ContactSven Wellmann

KinderUniKlinik Ostbayern (KUNO), Klinik St. Hedwig, Barmherzige Brüder Regensburg

sven.wellmann@barmherzige-regensburg.de+49 (0) 941 369-5401

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026